Agilent Technologies (A) Stock: Buy, Sell, or Hold?
A - Agilent Technologies Inc.
$173.07
-0.82 (-0.47%)
âŧ
5d:
+0.06%
30d:
+0.13%
90d:
+25.51%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 23, 2026
30d
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: A is fairly priced but lacks strong directional signals. At 7.4% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: A is fairly priced but lacks strong directional signals. At 7.4% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$189.77
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$117.83
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $173.07, which is considered slightly high relative to its 30-day fair value range of $160.34 to $175.81. From a valuation perspective, the stock is trading at a premium (Forward PE: 25.7) compared to its historical average (20.7). At these levels, the market is pricing in 7.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, A is in a strong uptrend. The price is currently testing key support at $169.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: A scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, A is in a strong uptrend. The price is currently testing key support at $169.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: A scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$160.34 -
$175.81
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
37.1%
Protect Your Profits
Holding A? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($180.58)
- NEUTRAL: Trading at premium valuation - market expects 7.4% growth which is achievable
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$160.34 -
$175.81
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$169.59
Resistance Level
$179.10
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.67
Wall Street Target
$180.58
(+4.3%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
8.5%
Profit Margin
19.5%
Valuation Premium vs History
+7.4% premium
PE vs Historical
25.7 vs 20.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.4%
(market-implied from PE analysis)
1-Year Target
$185.88
(+7%)
2-Year Target
$199.63
(+15%)
3-Year Target
$214.40
(+24%)
3-Yr Target (if PE normalizes)
(PE: 26â21)
PE COMPRESSION
$172.91
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.7, Growth: 8.7%)
$222.42
(+29%)
Base:
(SPY PE: 19.9, Growth: 8.7%)
$172.09
(-1%)
Bear:
(PE: 16.9, Growth: 8.7%)
$146.28
(-16%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 34.12 | Current EPS (TTM): $5.21
Bull Case
$253.21
(+46%)
Analyst growth 29.5%, PE expands to 37.5
Base Case
$230.19
(+32%)
Market implied 29.5%, PE stable at 34.1
Bear Case
$120.87
(-31%)
Severe decline -20.0%, PE contracts to 29.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 5:51 PM ET
Data refreshes hourly during market hours. Next update: 6:51 PM
Data refreshes hourly during market hours. Next update: 6:51 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 67 BUY |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
28 analysts |
$691 | 48 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 45 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
